Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-26

Clinical Trial Update: Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating endovascular treatment with or without preceding intravenous tenecteplase in late-window acute ischemic stroke due to middle cerebral a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tenecteplase (TNKase) (tenecteplase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Ischemic Stroke, Acute, Thrombolysis | Phase 3 | Status: COMPLETED